Not only is it violating our patents, which we take very seriously, but it's really a direct challenge to the entire drug approval framework in the United States." Hims & Hers officials declined an interview request but said in a statement that treating obesity requires "precision and personalization." The company still sells injectable GLP-1 medications
If you notice adverse effects (e.g., increased nighttime awakenings, headaches, mood shifts, altered blood pressure, hormonal imbalance) reduce dose or discontinue and consult a qualified specialist
Recognizing neutrophils as central drivers of immuno-metabolic dysfunction highlights the therapeutic potential of targeting the neutrophilNET axis
Nhng ngi ln da b chy nng, c du hiu lo ha sm
EA can regulate gut microbiota to activate more indole-3-propionic acid, thereby affecting melatonin receptors and improving symptoms in middle cerebral artery occlusion (MCAO) mice (Li S
PK-A phosphorylates sites on the sarcoplasmic reticulum, which leads to enhanced release of calcium through the ryanodine receptors (ryanodine-sensitive, calcium-release channels) associated with the sarcoplasmic reticulum
